🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06615661
Active, not recruiting Observational

A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma

NCT06615661 · tracked via the Priya Life Science USA tracker
Sponsor
Iantrek, Inc.
Phase
Observational
Started
2024-08-14
Last updated
2026-07-21

Condition(s) studied

Primary Open Angle Glaucoma (POAG)

Investigational drug(s) / intervention(s)

C-Rex Instrument

C-Rex Instrument: The C-Rex Instrument is a manual ophthalmic surgical instrument used for ab interno goniotomy and inner wall trabeculotomy.

Study summary

This study enrolls adults with primary open angle glaucoma (POAG) who underwent goniotomy intraocular pressure (IOP)-lowering surgery with the C-Rex Instrument. Patients are consented prior to surgery and followed for 12 months postoperatively. Data regarding IOP, use of glaucoma medications, and any device-related complications are collected during the study time period.

Eligibility

Sex
ALL
Min age
22 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Primary open angle glaucoma * Goniotomy surgery performed using the C-Rex Instrument Exclusion Criteria: * History of intraocular surgery within 8 weeks prior to C-Rex surgery * Preoperative IOP higher than 33 mmHg * Presence of a glaucoma type other than POAG * Presence of clinically significant intraocular pathology other than cataract or glaucoma

Primary outcome measure(s)

Trial sites (6)

FacilityCityRegionStatus
CIRCLE Site 32 Cape Coral Florida
CIRCLE Site 10 DeLand Florida
CIRCLE Site 07 Atlanta Georgia
CIRCLE Site 30 Brentwood New York
CIRCLE Site 31 Rockville Centre New York
CIRCLE Site 04 Crossville Tennessee

More Iantrek, Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06615661 on ClinicalTrials.gov ↗ ← All trials in the USA